Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Antivenom Market 2017 Forecast to 2022

Table of Contents

1 Market Overview

• 1.1 Antivenom Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Polyvalent antivenom
  • 1.2.2 Monovalent antivenom
• 1.3 Market Analysis by Applications
  • 1.3.1 Retail Pharmacies
  • 1.3.2 Hospitals
  • 1.3.3 Others
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (USA, Canada and Mexico)
    • 1.4.1.1 USA Market States and Outlook (2012-2022)
    • 1.4.1.2 Canada Market States and Outlook (2012-2022)
    • 1.4.1.3 Mexico Market States and Outlook (2012-2022)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2012-2022)
    • 1.4.2.2 France Market States and Outlook (2012-2022)
    • 1.4.2.3 UK Market States and Outlook (2012-2022)
    • 1.4.2.4 Russia Market States and Outlook (2012-2022)
    • 1.4.2.5 Italy Market States and Outlook (2012-2022)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2012-2022)
    • 1.4.3.2 Japan Market States and Outlook (2012-2022)
    • 1.4.3.3 Korea Market States and Outlook (2012-2022)
    • 1.4.3.4 India Market States and Outlook (2012-2022)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2012-2022)
    • 1.4.4.2 Egypt Market States and Outlook (2012-2022)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
    • 1.4.4.4 South Africa Market States and Outlook (2012-2022)
    • 1.4.4.5 Nigeria Market States and Outlook (2012-2022)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 CSL Behring
  • 2.1.1 Business Overview
    • 2.1.1.1 CSL Behring Antivenom Description
    • 2.1.1.2 CSL Behring Antivenom Headquarter, Main Business and Finance Overview
  • 2.1.2 CSL Behring Antivenom Product Introduction
    • 2.1.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.1.2.2 CSL Behring Antivenom Product Introduction
  • 2.1.3 CSL Behring Antivenom Sales, Revenue and Market Share
    • 2.1.3.1 CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.1.3.2 CSL Behring Antivenom Market Share in Global in 2016
• 2.2 Merck & Co., Inc.
  • 2.2.1 Business Overview
    • 2.2.1.1 Merck & Co., Inc. Antivenom Description
    • 2.2.1.2 Merck & Co., Inc. Antivenom Headquarter, Main Business and Finance Overview
  • 2.2.2 CSL Behring Antivenom Product Introduction
    • 2.2.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.2.2.2 Merck & Co., Inc. Antivenom Product Introduction
  • 2.2.3 Merck & Co., Inc. Antivenom Sales, Revenue and Market Share
    • 2.2.3.1 Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2.3.2 Merck & Co., Inc. Antivenom Market Share in Global in 2016
• 2.3 BTG Plc
  • 2.3.1 Business Overview
    • 2.3.1.1 BTG Plc Antivenom Description
    • 2.3.1.2 BTG Plc Antivenom Headquarter, Main Business and Finance Overview
  • 2.3.2 BTG Plc Antivenom Product Introduction
    • 2.3.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.3.2.2 BTG Plc Antivenom Product Introduction
  • 2.3.3 BTG Plc Antivenom Sales, Revenue and Market Share
    • 2.3.3.1 BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3.3.2 BTG Plc Antivenom Market Share in Global in 2016
• 2.4 Pfizer
  • 2.4.1 Business Overview
    • 2.4.1.1 Pfizer Antivenom Description
    • 2.4.1.2 Pfizer Antivenom Headquarter, Main Business and Finance Overview
  • 2.4.2 Pfizer Antivenom Product Introduction
    • 2.4.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.4.2.2 Pfizer Antivenom Product Introduction
  • 2.4.3 Pfizer Antivenom Sales, Revenue and Market Share
    • 2.4.3.1 Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4.3.2 Pfizer Antivenom Market Share in Global in 2016
• 2.5 Haffkine Bio-Pharmaceutical Corporation
  • 2.5.1 Business Overview
    • 2.5.1.1 Haffkine Bio-Pharmaceutical Corporation Antivenom Description
    • 2.5.1.2 Haffkine Bio-Pharmaceutical Corporation Antivenom Headquarter, Main Business and Finance Overview
  • 2.5.2 Haffkine Bio-Pharmaceutical Corporation Antivenom Product Introduction
    • 2.5.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.5.2.2 Haffkine Bio-Pharmaceutical Corporation Antivenom Product Introduction
  • 2.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Revenue and Market Share
    • 2.5.3.1 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5.3.2 Haffkine Bio-Pharmaceutical Corporation Antivenom Market Share in Global in 2016
• 2.6 Rare Disease Therapeutics
  • 2.6.1 Business Overview
    • 2.6.1.1 Rare Disease Therapeutics Antivenom Description
    • 2.6.1.2 Rare Disease Therapeutics Antivenom Headquarter, Main Business and Finance Overview
  • 2.6.2 Rare Disease Therapeutics Antivenom Product Introduction
    • 2.6.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.6.2.2 Rare Disease Therapeutics Antivenom Product Introduction
  • 2.6.3 Rare Disease Therapeutics Antivenom Sales, Revenue and Market Share
    • 2.6.3.1 Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6.3.2 Rare Disease Therapeutics Antivenom Market Share in Global in 2016
• 2.7 Flynn Pharma
  • 2.7.1 Business Overview
    • 2.7.1.1 Flynn Pharma Antivenom Description
    • 2.7.1.2 Flynn Pharma Antivenom Headquarter, Main Business and Finance Overview
  • 2.7.2 Flynn Pharma Antivenom Product Introduction
    • 2.7.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.7.2.2 Flynn Pharma Antivenom Product Introduction
  • 2.7.3 Flynn Pharma Antivenom Sales, Revenue and Market Share
    • 2.7.3.1 Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7.3.2 Flynn Pharma Antivenom Market Share in Global in 2016
• 2.8 Vins Bioproducts
  • 2.8.1 Business Overview
    • 2.8.1.1 Vins Bioproducts Antivenom Description
    • 2.8.1.2 Vins Bioproducts Antivenom Headquarter, Main Business and Finance Overview
  • 2.8.2 Vins Bioproducts Antivenom Product Introduction
    • 2.8.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.8.2.2 Vins Bioproducts Antivenom Product Introduction
  • 2.8.3 Vins Bioproducts Antivenom Sales, Revenue and Market Share
    • 2.8.3.1 Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8.3.2 Vins Bioproducts Antivenom Market Share in Global in 2016
• 2.9 Bharat Serums and Vaccines
  • 2.9.1 Business Overview
    • 2.9.1.1 Bharat Serums and Vaccines Antivenom Description
    • 2.9.1.2 Bharat Serums and Vaccines Antivenom Headquarter, Main Business and Finance Overview
  • 2.9.2 Bharat Serums and Vaccines Antivenom Product Introduction
    • 2.9.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.9.2.2 Bharat Serums and Vaccines Antivenom Product Introduction
  • 2.9.3 Bharat Serums and Vaccines Antivenom Sales, Revenue and Market Share
    • 2.9.3.1 Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9.3.2 Bharat Serums and Vaccines Antivenom Market Share in Global in 2016
• 2.10 Serum Biotech
  • 2.10.1 Business Overview
    • 2.10.1.1 Serum Biotech Antivenom Description
    • 2.10.1.2 Serum Biotech Antivenom Headquarter, Main Business and Finance Overview
  • 2.10.2 Serum Biotech Antivenom Product Introduction
    • 2.10.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.10.2.2 Serum Biotech Antivenom Product Introduction
  • 2.10.3 Serum Biotech Antivenom Sales, Revenue and Market Share
    • 2.10.3.1 Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.10.3.2 Serum Biotech Antivenom Market Share in Global in 2016

  3 Global Antivenom Market Competition, by Manufacturer

  • 3.1 Global Antivenom Sales and Market Share by Manufacturer (2016-2017)
  • 3.2 Global Antivenom Revenue and Market Share by Manufacturer (2016-2017)
  • 3.3 Global Antivenom Price by Manufacturer (2016-2017)
  • 3.4 Market Concentration Rate
    • 3.4.1 Top 3 Antivenom Manufacturer Market Share
    • 3.4.2 Top 5 Antivenom Manufacturer Market Share
  • 3.5 Market Competition Trend

  4 Global Antivenom Market Analysis by Regions

  • 4.1 Global Antivenom Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Antivenom Sales by Regions (2012-2017)
    • 4.1.2 Global Antivenom Revenue by Regions (2012-2017)
  • 4.2 North America Antivenom Sales and Growth (2012-2017)
  • 4.3 Europe Antivenom Sales and Growth (2012-2017)
  • 4.4 Asia-Pacific Antivenom Sales and Growth (2012-2017)
  • 4.5 South America Antivenom Sales and Growth (2012-2017)
  • 4.6 Middle East and Africa Antivenom Sales and Growth (2012-2017)

  5 North America Antivenom by Countries, Type, Application and Manufacturers

  • 5.1 North America Antivenom Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Antivenom Sales by Countries (2012-2017)
    • 5.1.2 North America Antivenom Revenue by Countries (2012-2017)
    • 5.1.3 USA Antivenom Sales and Growth (2012-2017)
    • 5.1.4 Canada Antivenom Sales and Growth (2012-2017)
    • 5.1.5 Mexico Antivenom Sales and Growth (2012-2017)
  • 5.2 North America Antivenom Sales and Revenue (value) by Manufacturers (2016-2017)
    • 5.2.1 North America Antivenom Sales by Manufacturers (2016-2017)
    • 5.2.2 North America Antivenom Revenue by Manufacturers (2016-2017)
  • 5.3 North America Antivenom Sales by Type (2012-2017)
  • 5.4 North America Antivenom Sales by Application (2012-2017)

  6 Europe Antivenom by Countries, Type, Application and Manufacturers

  • 6.1 Europe Antivenom Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Antivenom Sales by Countries (2012-2017)
    • 6.1.2 Europe Antivenom Revenue by Countries (2012-2017)
    • 6.1.3 Germany Antivenom Sales and Growth (2012-2017)
    • 6.1.4 UK Antivenom Sales and Growth (2012-2017)
    • 6.1.5 France Antivenom Sales and Growth (2012-2017)
    • 6.1.6 Russia Antivenom Sales and Growth (2012-2017)
    • 6.1.7 Italy Antivenom Sales and Growth (2012-2017)
  • 6.2 Europe Antivenom Sales and Revenue (value) by Manufacturers (2016-2017)
    • 6.2.1 Europe Antivenom Sales by Manufacturers (2016-2017)
    • 6.2.2 Europe Antivenom Revenue by Manufacturers (2016-2017)
  • 6.3 Europe Antivenom Sales by Type (2012-2017)
  • 6.4 Europe Antivenom Sales by Application (2012-2017)

  7 Asia-Pacific Antivenom by Countries, Type, Application and Manufacturers

  • 7.1 Asia-Pacific Antivenom Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Antivenom Sales by Countries (2012-2017)
    • 7.1.2 Asia-Pacific Antivenom Revenue by Countries (2012-2017)
    • 7.1.3 China Antivenom Sales and Growth (2012-2017)
    • 7.1.4 Japan Antivenom Sales and Growth (2012-2017)
    • 7.1.5 Korea Antivenom Sales and Growth (2012-2017)
    • 7.1.6 India Antivenom Sales and Growth (2012-2017)
    • 7.1.7 Southeast Asia Antivenom Sales and Growth (2012-2017)
  • 7.2 Asia-Pacific Antivenom Sales and Revenue (value) by Manufacturers (2016-2017)
    • 7.2.1 Asia-Pacific Antivenom Sales by Manufacturers (2016-2017)
    • 7.2.2 Asia-Pacific Antivenom Revenue by Manufacturers (2016-2017)
  • 7.3 Asia-Pacific Antivenom Sales by Type (2012-2017)
  • 7.4 Asia-Pacific Antivenom Sales by Application (2012-2017)

  8 South America Antivenom by Countries, Type, Application and Manufacturers

  • 8.1 South America Antivenom Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Antivenom Sales by Countries (2012-2017)
    • 8.1.2 South America Antivenom Revenue by Countries (2012-2017)
    • 8.1.3 Brazil Antivenom Sales and Growth (2012-2017)
    • 8.1.4 Argentina Antivenom Sales and Growth (2012-2017)
    • 8.1.5 Columbia Antivenom Sales and Growth (2012-2017)
  • 8.2 South America Antivenom Sales and Revenue (value) by Manufacturers (2016-2017)
    • 8.2.1 South America Antivenom Sales by Manufacturers (2016-2017)
    • 8.2.2 South America Antivenom Revenue by Manufacturers (2016-2017)
  • 8.3 South America Antivenom Sales by Type (2012-2017)
  • 8.4 South America Antivenom Sales by Application (2012-2017)

  9 Middle East and Africa Antivenom by Countries, Type, Application and Manufacturers

  • 9.1 Middle East and Africa Antivenom Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Antivenom Sales by Countries (2012-2017)
    • 9.1.2 Middle East and Africa Antivenom Revenue by Countries (2012-2017)
    • 9.1.3 Saudi Arabia Antivenom Sales and Growth (2012-2017)
    • 9.1.4 UAE Antivenom Sales and Growth (2012-2017)
    • 9.1.5 Egypt Antivenom Sales and Growth (2012-2017)
    • 9.1.6 Nigeria Antivenom Sales and Growth (2012-2017)
    • 9.1.7 South Africa Antivenom Sales and Growth (2012-2017)
  • 9.2 Middle East and Africa Antivenom Sales and Revenue (value) by Manufacturers (2016-2017)
    • 9.2.1 Middle East and Africa Antivenom Sales by Manufacturers (2016-2017)
    • 9.2.2 Middle East and Africa Antivenom Revenue by Manufacturers (2016-2017)
  • 9.3 Middle East and Africa Antivenom Sales by Type (2012-2017)
  • 9.4 Middle East and Africa Antivenom Sales by Application (2012-2017)

  10 Global Antivenom Market Segment by Type

  • 10.1 Global Antivenom Sales, Revenue and Market Share by Type (2012-2017)
    • 10.1.1 Global Antivenom Sales and Market Share by Type (2012-2017)
    • 10.1.2 Global Antivenom Revenue and Market Share by Type (2012-2017)
  • 10.2 Polyvalent antivenom Sales Growth and Price
    • 10.2.1 Global Polyvalent antivenom Sales Growth (2012-2017)
    • 10.2.2 Global Polyvalent antivenom Price (2012-2017)
  • 10.3 Monovalent antivenom Sales Growth and Price
    • 10.3.1 Global Monovalent antivenom Sales Growth (2012-2017)
    • 10.3.2 Global Monovalent antivenom Price (2012-2017)

  11 Global Antivenom Market Segment by Application

  • 11.1 Global Antivenom Sales Market Share by Application (2012-2017)
  • 11.2 Retail Pharmacies Sales Growth (2012-2017)
  • 11.3 Hospitals Sales Growth (2012-2017)
  • 11.4 Others Sales Growth (2012-2017)

  12 Antivenom Market Forecast (2017-2022)

  • 12.1 Global Antivenom Sales, Revenue and Growth Rate (2017-2022)
  • 12.2 Antivenom Market Forecast by Regions (2017-2022)
    • 12.2.1 North America Antivenom Market Forecast (2017-2022)
    • 12.2.2 Europe Antivenom Market Forecast (2017-2022)
    • 12.2.3 Asia-Pacific Antivenom Market Forecast (2017-2022)
    • 12.2.4 South America Antivenom Market Forecast (2017-2022)
    • 12.2.5 Middle East and Africa Antivenom Market Forecast (2017-2022)
  • 12.3 Antivenom Market Forecast by Type (2017-2022)
  • 12.4 Antivenom Market Forecast by Application (2017-2022)

  13 Sales Channel, Distributors, Traders and Dealers

  • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
    • 13.1.2 Indirect Marketing
    • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers

  14 Research Findings and Conclusion

  15 Appendix

  • 15.1 Methodology
  • 15.2 Analyst Introduction